前收市價 | 107.85 |
開市 | 66.03 |
買盤 | 63.84 x 200 |
賣出價 | 64.02 x 100 |
今日波幅 | 62.34 - 67.44 |
52 週波幅 | 62.34 - 142.00 |
成交量 | |
平均成交量 | 3,579,029 |
市值 | 25.645B |
Beta 值 (5 年,每月) | 無 |
市盈率 (最近 12 個月) | 39.75 |
每股盈利 (最近 12 個月) | 1.61 |
業績公佈日 | 2024年10月24日 - 2024年10月28日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 151.17 |
Dexcom stock plummeted early Friday after the diabetes devices maker reported light June-quarter sales and slashed its outlook.
Stocks rose sharply Friday after the personal consumption expenditures price index, the report the Federal Reserve considers the most accurate measure of price inflation, matched expectations. The data have analysts and economists expecting an interest-rate cut from the Fed in September.
DexCom's (DXCM) second-quarter 2024 earnings surpass expectations while revenues fall short. The Sensor segment and CGM system expansion drive growth. Shares fall.